DILANTIN-125
Asset
- Stage
- Approved
- Modality
- Not known
- Target
- Not known
- 1
- Indication
- 46
- Trials
- 1
- Developer
Approved by the FDA on Jan 6, 1953 (NDA008762). FDA
Indications
1No named disease
Approved, FDA, Jan 6, 1953
In the full profile
- Target and mechanism1
- Owner and partners1
- Trials46
- Evidence for its targets1
- Competitors1
Every asset’s record: target, stage, trials and the evidence behind it.